KUALA LUMPUR: Kenanga Research expects IHH Healthcare Bhd's growth for the next five years to be driven by its operations in Singapore, Malaysia and Turkey.
In a research note today, it said in Singapore, the first phase of Mount Elizabeth Novena hospital, comprising of 150 beds of the 333-bed capacity and 13 operation theatres had commenced operations in July last year.
In Malaysia, it said the company was currently undertaking expansion projects in four hospitals -- Gleneagles Medical Centre Penang, Pantai Hospital Kuala Lumpur, Pantai Hospital Klang and Gleneagles, Kuala Lumpur -- and greenfield projects namely Gleneagles Kota Kinabalu, Pantai Hospital Manjung and Gleneagles Medini.
"The three greenfield projects will add an estimated 500 beds to its network by 2014," it said.
Meanwhile, in Turkey, the company through its subsidiary, Acibadem, is currently undertaking expansion projects in two hospitals, Acibadem Sistina Skopje Clinical Hospital and Acibadem Maslak Hospital, while undertaking two greenfield projects, Acibadem Ankara and Bodrum Hospitals.
AmResearch, in a separate note, said a growth frontier for the group would be Hong Kong, making its foray via winning a site for a greenfield project in the former British colony, which is scheduled for commencement in financial year 2016.
"This acts as a platform to penetrate deeper into the large and underserved market of Hong Kong," it said.
Nevertheless, it said IHH Healthcare was expected to continue its efforts to intensify revenue and exposure in its three key markets, Malaysia, Singapore and Turkey, to propel growth further underpinned by strong franchise value.
Kenanga has maintained its "market perform" call on the stock and raised the target price to RM4.04 from RM3.51 previously.
AmResearch re-affirmed a "hold" recommendation with an unchanged fair value of RM3.25. -- BERNAMA
Read more: Kenanga: 3 countries to drive IHH Healthcare's growth http://www.btimes.com.my/Current_News/BTIMES/articles/20130527133428/Article/#ixzz2UVDIY15Y
In a research note today, it said in Singapore, the first phase of Mount Elizabeth Novena hospital, comprising of 150 beds of the 333-bed capacity and 13 operation theatres had commenced operations in July last year.
In Malaysia, it said the company was currently undertaking expansion projects in four hospitals -- Gleneagles Medical Centre Penang, Pantai Hospital Kuala Lumpur, Pantai Hospital Klang and Gleneagles, Kuala Lumpur -- and greenfield projects namely Gleneagles Kota Kinabalu, Pantai Hospital Manjung and Gleneagles Medini.
"The three greenfield projects will add an estimated 500 beds to its network by 2014," it said.
Meanwhile, in Turkey, the company through its subsidiary, Acibadem, is currently undertaking expansion projects in two hospitals, Acibadem Sistina Skopje Clinical Hospital and Acibadem Maslak Hospital, while undertaking two greenfield projects, Acibadem Ankara and Bodrum Hospitals.
AmResearch, in a separate note, said a growth frontier for the group would be Hong Kong, making its foray via winning a site for a greenfield project in the former British colony, which is scheduled for commencement in financial year 2016.
"This acts as a platform to penetrate deeper into the large and underserved market of Hong Kong," it said.
Nevertheless, it said IHH Healthcare was expected to continue its efforts to intensify revenue and exposure in its three key markets, Malaysia, Singapore and Turkey, to propel growth further underpinned by strong franchise value.
Kenanga has maintained its "market perform" call on the stock and raised the target price to RM4.04 from RM3.51 previously.
AmResearch re-affirmed a "hold" recommendation with an unchanged fair value of RM3.25. -- BERNAMA
Read more: Kenanga: 3 countries to drive IHH Healthcare's growth http://www.btimes.com.my/Current_News/BTIMES/articles/20130527133428/Article/#ixzz2UVDIY15Y
No comments:
Post a Comment